Latest On Catalyst Biosciences, Inc (CBIO):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-02-28 18:02 EST | News | Catalyst stock surges 95% as GC Biopharma to acquire 3 blood disorder programs | N/A |  |
| 2023-01-13 04:42 EST | Dividend | A dividend of $0.24 has been announced on Dec 27, 2022. It will be paid Jan 12, 2023 with an ex-dividend date of Jan 13, 2023. | Neutral | |
| 2022-12-27 19:55 EST | News | Catalyst Biosciences closes first steps in reverse merger plan | N/A | |
| 2022-09-02 05:42 EST | Dividend | A dividend of $1.43 has been announced on Aug 25, 2022. It will be paid Sep 20, 2022 with an ex-dividend date of Sep 2, 2022. | Neutral | |
| 2022-08-25 10:12 EST | News | Catalyst Biosciences declares special one-time dividend of $1.43 | N/A | |
| 2022-08-16 05:35 EST | News | Catalyst Biosciences GAAP EPS of $1.64 | N/A | |
| 2022-08-15 12:34 EST | News | Catalyst Biosciences: Shareholders Should Reap Benefits From Owning The Stock | N/A | |
| 2022-06-29 13:40 EST | News | Catalyst Biosciences plans to distribute $65M cash to stockholders | N/A | |
| 2022-05-23 15:48 EST | News | Vertex agrees to buy protease drugs from Catalyst Bio | N/A | |
| 2022-05-10 03:27 EST | News | Catalyst Biosciences GAAP EPS of -$0.46 misses by $0.02, revenue of $0.8M | N/A | |
| 2022-04-01 04:02 EST | News | Catalyst Biosciences GAAP EPS of -$2.87 misses by $0.01, revenue of $7.34M beats by $2.19M | N/A | |
| 2022-03-17 04:18 EST | News | Biogen ends partnership with Catalyst Biosciences for eye disease candidate | N/A | |
| 2022-01-25 10:19 EST | News | Catalyst Bio's stock jumps 21% after securing Rare Pediatric Disease tag for CB 4332 | N/A | |
| 2021-12-17 19:57 EST | News | Catalyst granted FDA’s orphan drug designation for hemophilia drug | N/A | |
| 2021-12-08 03:45 EST | News | Circling Back On Catalyst Biosciences | N/A | |
| 2021-11-23 19:01 EST | News | Warning: CBIO is at high risk of performing badly | N/A | |
| 2021-11-12 18:24 EST | News | Catalyst Biosciences EPS misses by $0.14, beats on revenue | N/A | |
| 2021-10-13 18:39 EST | News | Catalyst Biosciences CFO resigns, interim replacement named | N/A | |
| 2021-09-29 12:01 EST | News | Catalyst wins Orphan Drug designation for MarzAA, for Factor VII Deficiency | N/A | |
| 2021-09-27 14:28 EST | News | Catalyst Biosciences granted FDA’s orphan drug status for bleeding disorder therapy | N/A | |
| 2021-08-05 23:51 EST | News | Catalyst Biosciences EPS beats by $0.06, beats on revenue | N/A | |
| 2021-07-22 20:34 EST | News | Catalyst Biosciences screens first patient in CFI-deficiency study | N/A | |
| 2021-07-20 23:34 EST | News | Catalyst Biosciences shares rise on FDA Fast Track status for MarzAA | N/A | |
| 2021-05-06 08:59 EST | News | Catalyst Biosciences EPS misses by $0.12, beats on revenue | N/A | |
| 2021-03-08 11:17 EST | Analyst Rating | The Analyst Target Price has decreased from $18.2 to $17.8. | Neutral | |
| 2021-03-05 23:21 EST | Financials | Company financials have been released. | Neutral | |
| 2021-03-05 15:16 EST | Analyst Rating | The Analyst Target Price has decreased from $19.2 to $18.2. | Neutral | |
| 2021-03-05 15:16 EST | Earnings Estimate | An EPS average of -$2.85 is estimated for the 2022 year. | Sell | |
| 2021-03-05 15:16 EST | Earnings Estimate | An EPS average of -$0.68 is estimated for the quarter ending on June 30, 2021. | Buy | |
| 2021-03-04 19:16 EST | News | Catalyst Biosciences EPS misses by $0.26, beats on revenue | N/A | |
| 2021-03-04 19:15 EST | News | Catalyst Biosciences (CBIO) Presents At 42nd Annual Raymond James Institutional Investors Conference | N/A | |
| 2021-02-11 11:16 EST | Analyst Rating | The Analyst Target Price has decreased from $19.75 to $19.2. | Neutral | |
| 2021-02-04 15:19 EST | Analyst Rating | The Analyst Target Price has decreased from $20.25 to $19.75. | Neutral | |
| 2021-01-30 09:12 EST | News | Catalyst Biosciences announces closing of $50M capital raise | N/A | |
| 2021-01-27 13:04 EST | News | Catalyst Bio down 5% on launch of public offering | N/A | |
| 2021-01-27 13:04 EST | News | Catalyst Biosciences under pressure on pricing 8.7M equity offering | N/A | |
| 2021-01-26 21:35 EST | News | Catalyst Biosciences down 5% after launching underwritten public offering | N/A | |
| 2020-12-13 03:27 EST | Financials | Company financials have been released. | Neutral | |
| 2020-12-02 18:23 EST | News | Catalyst Bio Factor VIIa variant Fast Track'd in U.S. for hemophilia | N/A | |
| 2020-11-18 09:39 EST | News | Catalyst Biosciences (CBIO) Presents At Stifel 2020 Virtual Healthcare Conference - Slideshow | N/A | |
| 2020-11-15 11:32 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-13 23:17 EST | News | Catalyst Biosciences: After 2 Fundraisings, A Lengthy Wait For Pivotal Trial Data Is Next | N/A | |
| 2020-11-10 03:22 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-06 11:20 EST | Earnings Estimate | An EPS average of -$0.82 is estimated for the quarter ending on March 31, 2021. | Sell | |
| 2020-11-06 04:26 EST | News | Catalyst Biosciences EPS beats by $0.06 | N/A | |
| 2020-11-01 17:27 EST | Financials | Company financials have been released. | Neutral | |
| 2020-10-14 08:46 EST | News | Catalyst Bio secures US patent for engineered proteases | N/A | |
| 2020-10-02 17:05 EST | Insider Trade | Geoffrey M.D. Ling has directly acquired 2,616 shares and currently holds 9,251 shares. | Buy | |
| 2020-10-02 17:05 EST | Insider Trade | Eddie Williams has directly acquired 1,380 shares and currently holds 15,947 shares. | Buy | |
| 2020-10-02 16:21 EST | Insider Trade | ERROL B DESOUZA has directly acquired 3,125 shares and currently holds 17,752 shares. | Buy | |
About Catalyst Biosciences, Inc (CBIO):
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company engineer proteases to develop improved or novel molecules to treat diseases that result from dysregulation of the complement and coagulation cascades. Its protease engineering platform has generated two late-stage clinical programs, including marzeptacog alfa (MarzAA), a subcutaneously administered engineered coagulation; and Factor VIIa (FVIIa) for the treatment of episodic bleeding in subjects with rare bleeding disorders. The company's pipeline also includes a preclinical program partnered with Biogen International GmbH for dry age-related macular degeneration (AMD); factor I protease for SQ prophylaxis in patients with complement factor I deficiency and C4b-degraders designed to target disorders of the classical complement pathway, as well as other complement programs. The company also develops CB 4332 intended for lifelong prophylactic SQ administration in individuals with CFI deficiency; and CB 2782-PEG, a C3 degrader product candidate in preclinical development for the treatment of dry AMD. It has a strategic research collaboration with Mosaic Biosciences, Inc. to develop intravitreal anti-complement factor 3 products for the treatment of dry AMD and other retinal diseases; and license and collaboration agreement with Biogen International GmbH for the development and commercialization of pegylated CB 2782 (anti-C3 protease) to treat geographic atrophy associated dry AMD. Catalyst Biosciences, Inc. was founded in 2002 and is headquartered in South San Francisco, California.
General
- Name Catalyst Biosciences, Inc
- Symbol CBIO
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 56
- Last Split Factor1:15
- Last Split Date2017-02-13
- Fiscal Year EndDecember
- IPO Date2006-04-12
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.catalystbiosciences.com
View More
Valuation
- Price/Sales (Trailing 12 Mt.) 5.6
- Price/Book (Most Recent Quarter) 2.52
- Enterprise Value Revenue 5.44
- Enterprise Value EBITDA 0.28
View More
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$2.79
- Next Year EPS Estimate -$3.03
- Next Quarter EPS Estimate -$0.74
- Profit Margin -268%
- Operating Margin -270%
- Return on Assets -37%
- Return on Equity -78%
- Revenue 20.95 million
- Earnings Per Share -$3.96
- Revenue Per Share $1.09
- Gross Profit -40390000
- Quarterly Earnings Growth 0%
View More
Highlights
- Market Capitalization 182.66 million
- EBITDA -49865000
- PE Ratio -2.42
- PEG Ratio 0.02
- Analyst Target Price $17.8
- Book Value Per Share $3.44
View More
Share Statistics
- Shares Outstanding 30.8 million
- Shares Float 26.29 million
- % Held by Insiders 455%
- % Held by Institutions 64.58%
- Shares Short 733330
- Shares Short Prior Month 552002
- Short Ratio 0.9
- Short % of Float 2%
- Short % of Shares Outstanding 2%
View More
Technicals
- Beta 1.99
- 52 Week High $8.22
- 52 Week Low $3.62
- 50 Day Moving Average 6.17
- 200 Day Moving Average 5.77
View More
Dividends
- Dividend Date 2017-02-13
- ExDividend Date 2015-08-20
- Dividend Yield 0%
View More
Catalyst Biosciences, Inc (CBIO) Dividend Calendar:
CBIO's last dividend payment was made to shareholders on February 13, 2017.
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Catalyst Biosciences, Inc (CBIO) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-03-04 | $N/A | -$0.88 | -$0.89 | 0.76% |
| 2020-09-30 | 2020-11-05 | $893000 | -$0.73 | -$0.91 | 19.78% |
| 2020-06-30 | 2020-08-06 | $N/A | -$0.96 | -$0.89 | -8.27% |
| 2020-03-31 | 2020-05-11 | $16.37 million | -$0.28 | -$0.36 | 22.22% |
| 2019-12-31 | 2020-02-20 | $N/A | -$1.13 | -$1.02 | -11.33% |
| 2019-09-30 | 2019-11-07 | $N/A | -$1.06 | -$1.05 | -1.44% |
| 2019-06-30 | 2019-08-01 | $N/A | -$1.15 | -$1.20 | 4.17% |
| 2019-03-31 | 2019-05-02 | $N/A | -$1.26 | -$1.10 | -14.55% |
| 2018-12-31 | 2019-03-07 | $6000 | -$0.93 | -$0.88 | -5.68% |
| 2018-09-30 | 2018-11-01 | $N/A | -$0.64 | -$0.57 | -12.28% |
| 2018-06-30 | 2018-08-02 | $-6000 | -$0.54 | -$0.70 | 22.86% |
| 2018-03-31 | 2018-05-03 | $6000 | -$0.56 | -$0.79 | 29.11% |
| 2017-12-31 | 2018-03-01 | $318000 | -$0.96 | -$1.37 | 29.93% |
| 2017-09-30 | 2017-11-02 | $318000 | -$1.34 | -$1.46 | 8.22% |
| 2017-06-30 | 2017-08-03 | $111000 | -$2.53 | -$1.07 | -136.45% |
| 2017-03-31 | 2017-05-11 | $271000 | -$4.57 | -$7.05 | 35.18% |
| 2016-12-31 | 2017-03-08 | $71000 | -$4.68 | -$7.05 | 33.62% |
| 2016-09-30 | 2016-11-03 | $109000 | -$6.00 | -$7.20 | 16.67% |
| 2016-06-30 | 2016-08-04 | $110000 | -$6.30 | -$4.65 | -35.48% |
| 2016-03-31 | 2016-05-05 | $109000 | -$4.71 | ||
| 2015-12-31 | 2016-03-09 | $1.58 million | -$6.73 | ||
| 2015-09-30 | 2015-11-06 | $109000 | -$14.00 | ||
| 2015-06-30 | 2015-07-31 | $860000 | -$13.44 | ||
| 2014-12-31 | 2015-03-16 | $127000 | -$14.70 | -$18.90 | 22.22% |
| 2014-09-30 | 2014-11-05 | $25000 | -$0.98 | -$1.54 | 36.36% |
| 2014-06-30 | 2014-08-06 | $36000 | -$25.20 | -$34.12 | 26.14% |
| 2014-03-31 | 2014-05-07 | $87000 | -$46.20 | -$38.85 | -18.92% |
| 2013-12-31 | 2014-02-13 | $93000 | -$42.00 | -$40.95 | -2.56% |
| 2013-09-30 | 2013-11-05 | $N/A | -$39.90 | -$40.60 | 1.72% |
| 2013-06-30 | 2013-08-06 | $-3536000 | -$38.85 | -$38.59 | -0.67% |
| 2013-03-31 | 2013-05-07 | $3.54 million | -$25.20 | -$35.70 | 29.41% |
| 2012-12-31 | 2013-02-13 | $590000 | -$49.35 | -$32.55 | -51.61% |
| 2012-09-30 | 2012-11-06 | $768000 | -$25.20 | -$42.79 | 41.11% |
| 2012-06-30 | 2012-08-07 | $33.65 million | $45.15 | $41.74 | 8.17% |
| 2012-03-31 | 2012-05-03 | $22.86 million | $7.35 | -$26.25 | 128% |
| 2011-12-31 | 2012-02-21 | -$30.45 | -$31.20 | 2.4% | |
| 2011-09-30 | 2011-11-01 | $18.96 million | -$28.35 | -$22.84 | -24.12% |
| 2011-06-30 | 2011-08-04 | $20.74 million | -$7.35 | -$22.50 | 67.33% |
| 2011-03-31 | 2011-05-05 | $43.05 | -$6.75 | 737.78% | |
| 2010-12-31 | 2011-02-10 | -$8.40 | -$1.97 | -326.4% | |
| 2010-09-30 | 2010-11-04 | $8.40 | -$1.35 | 722.22% | |
| 2010-06-30 | 2010-08-04 | $13.65 | $19.16 | -28.76% | |
| 2010-03-31 | 2010-05-05 | $24.15 | $15.75 | 53.33% | |
| 2009-12-31 | 2010-02-11 | -$100.80 | -$35.25 | -185.96% | |
| 2009-09-30 | 2009-11-05 | $5.25 | -$9.45 | 155.56% | |
| 2009-06-30 | 2009-08-05 | -$40.95 | -$33.18 | -23.42% | |
| 2009-03-31 | 2009-05-11 | -$19.95 | -$32.55 | 38.71% | |
| 2008-12-31 | 2009-02-12 | -$23.10 | -$34.86 | 33.73% | |
| 2008-09-30 | 2008-11-06 | -$32.55 | -$43.05 | 24.39% | |
| 2008-06-30 | 2008-08-05 | -$28.35 | -$37.01 | 23.4% | |
| 2008-03-31 | 2008-05-06 | -$25.20 | -$36.75 | 31.43% | |
| 2007-12-31 | 2008-02-12 | -$38.85 | -$30.45 | -27.59% | |
| 2007-09-30 | 2007-11-08 | -$38.85 | -$3.15 | -1133.33% | |
| 2007-06-30 | 2007-08-07 | -$36.75 | -$35.00 | -5% | |
| 2007-03-31 | 2007-05-09 | -$25.20 | -$35.17 | 28.35% | |
| 2006-12-31 | 2007-02-22 | $87.15 | $19.16 | 354.85% | |
| 2006-09-30 | 2006-11-09 | -$26.25 | -$38.33 | 31.52% | |
| 2006-06-30 | 2006-08-09 | -$34.65 | -$33.86 | -2.33% | |
| 2006-03-31 | 2006-05-25 | -$28.35 | -$48.65 | 41.73% |
Catalyst Biosciences, Inc (CBIO) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date | Dec 31 2020 | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 |
|---|---|---|---|---|---|
| Research Development | N/A | -12.25 million | N/A | 13.26 million | 43.86 million |
| Income Before Tax | N/A | -16.03 million | N/A | -4.05 million | -13.61 million |
| Selling General Administrative | N/A | -3.83 million | N/A | 3.69 million | 3.19 million |
| Gross Profit | N/A | 893000 | N/A | 11.89 million | 33.07 million |
| Ebit | N/A | -16.03 million | N/A | -5.04 million | -13.99 million |
| Operating Income | N/A | -16.1 million | N/A | -5.07 million | -13.99 million |
| Income Tax Expense | N/A | N/A | N/A | N/A | N/A |
| Total Revenue | N/A | 893000 | N/A | 16.37 million | N/A |
| Cost of Revenue | N/A | N/A | N/A | 4.48 million | -33.07 million |
| Total Other Income Expense Net | N/A | N/A | N/A | 681000 | 377000 |
| Net Income From Continuing Operations | N/A | -16.03 million | N/A | -4.05 million | -13.61 million |
| Net Income Applicable to Common Shares | -18.91 million | -16.03 million | -17.25 million | N/A | -13.61 million |
Cash Flow:
| Date | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 |
|---|---|---|---|---|---|
| Investments | -21.27 million | N/A | 27.42 million | 439000 | N/A |
| Change to Liabilities | 3.18 million | 513000 | N/A | 17.16 million | N/A |
| Total Cash Flow from Investing Activities | -21.27 million | -24.04 million | N/A | 440000 | N/A |
| Net Borrowings | N/A | N/A | N/A | N/A | N/A |
| Total Cash Flow from Financial Activities | -75000 | N/A | 32.36 million | N/A | N/A |
| Change to Operating Activities | -1.7 million | 1.36 million | N/A | 2.66 million | N/A |
| Change in Cash | -34.35 million | N/A | 55 million | -7.65 million | N/A |
| Total Cash from Operating Activities | -13.01 million | -15.14 million | -4.79 million | -8.09 million | N/A |
| Depreciation | 42000 | N/A | 25000 | 34000 | N/A |
| Other Cash Flow from Investing Activities | N/A | N/A | N/A | N/A | N/A |
| Change to Inventory | N/A | N/A | N/A | N/A | N/A |
| Change to Account Receivables | 433000 | N/A | 13.63 million | -15 million | N/A |
| Other Cash Flow from Financing Activities | -75000 | N/A | N/A | N/A | N/A |
| Change to Net Income | 1.07 million | 834000 | N/A | 671000 | N/A |
| Capital Expenditures | 195000 | N/A | 17000 | 1000 | N/A |
Balance Sheet:
| Date | Dec 31 2020 | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 |
|---|---|---|---|---|---|
| Total Liabailities | N/A | 17.75 million | N/A | 13.04 million | 30.22 million |
| Total Stockholder Equity | N/A | 94.06 million | N/A | 97.52 million | 68.34 million |
| Other Current Liabilities | 1.98 million | 764000 | N/A | N/A | 15 million |
| Total Assets | N/A | 111.8 million | N/A | 110.56 million | 98.55 million |
| Common Stock | 22000 | 22000 | 22000 | N/A | 12000 |
| Other Current Assets | N/A | 3.54 million | N/A | N/A | N/A |
| Retained Earnings | -314.76 million | -295.85 million | -279.82 million | -262.57 million | -258.52 million |
| Other Liabilities | N/A | N/A | N/A | N/A | N/A |
| Other Assets | 528000 | 698000 | 198000 | N/A | 257000 |
| Cash | N/A | 24.92 million | N/A | 70.36 million | 15.37 million |
| Total Current Liabilities | 17.8 million | 16.82 million | N/A | 11.85 million | 28.9 million |
| Other Stockholder Equity | 5000 | 8000 | 41000 | N/A | 34000 |
| Property, Plant & Equipment | 2.27 million | 1.96 million | 2.14 million | N/A | 2.23 million |
| Total Current Assets | 89.51 million | 107.97 million | N/A | 108.28 million | 96.07 million |
| Long Term Investments | N/A | 1.17 million | N/A | N/A | N/A |
| Net Tangible Assets | 76.07 million | 94.06 million | 108.96 million | N/A | 68.34 million |
| Short Term Investments | N/A | 77.96 million | N/A | 34.16 million | 61.5 million |
| Long Term Debt | N/A | N/A | N/A | N/A | N/A |
| Inventory | N/A | N/A | N/A | N/A | N/A |
| Accounts Payable | 5.93 million | 4.24 million | N/A | 1.32 million | 4.28 million |
Catalyst Biosciences, Inc (CBIO) Chart:
Catalyst Biosciences, Inc (CBIO) News:
Below you will find a list of latest news for Catalyst Biosciences, Inc (CBIO) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Catalyst Biosciences, Inc (CBIO) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|---|---|---|---|---|---|---|---|---|
| 2025-01-17 | 0.83 | 0.1 | CALL | 0 | 1906 | 207.33 | FALSE | 0 | 0 |
| 2025-01-17 | 1.07 | 0.15 | CALL | 1 | 950 | 0.5 | FALSE | 0 | 0 |
| 2025-01-17 | 3.33 | 0.05 | CALL | 0 | 45 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 5 | 0 | CALL | 0 | FALSE | 0 | 0 | ||
| 2025-01-17 | 5.83 | 0.05 | CALL | 0 | 45 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 6.07 | 0 | CALL | 0 | FALSE | 0 | 0 | ||
| 2025-01-17 | 0.83 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2025-01-17 | 1.07 | 0 | PUT | 0 | TRUE | 0 | 0 | ||
| 2025-01-17 | 3.33 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2025-01-17 | 5 | 0 | PUT | 0 | TRUE | 0 | 0 | ||
| 2025-01-17 | 5.83 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2025-01-17 | 6.07 | 0 | PUT | 0 | TRUE | 0 | 0 | ||
| 2032-10-21 | 1.07 | 0.05 | CALL | 98 | 606 | 0 | FALSE | 0.02 | 0.67 |
| 2032-10-21 | 6.07 | 0 | PUT | 0 | TRUE | 0 | 0 | ||
| 2032-11-18 | 6.07 | 0 | CALL | 0 | FALSE | 0 | 0 | ||
| 2032-11-18 | 1.07 | 0.35 | PUT | 1 | 1 | 0 | TRUE | -0.29 | -0.45 |
| 2032-12-16 | 1.07 | 0.05 | CALL | 40 | 12440 | 0 | FALSE | 0 | 0 |
Latest CBIO Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:59 PM EST | 100 | $1.325 |
| Jun 13, 2022 7:59 PM EST | 10 | $1.325 |
| Jun 13, 2022 7:59 PM EST | 100 | $1.325 |
| Jun 13, 2022 7:59 PM EST | 95 | $1.325 |
| Jun 13, 2022 7:59 PM EST | 5 | $1.325 |
Catalyst Biosciences, Inc (CBIO) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919120040433/0001209191-20-040433-index.htm |
| 2019-02-08 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1124105/000000000019001496/0000000000-19-001496-index.htm |
| 2019-02-08 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1124105/000021545719006624/0000215457-19-006624-index.htm |
| 2019-07-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1124105/000021545719008315/0000215457-19-008315-index.htm |
| 2019-07-24 | SC 13D | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1124105/000089843219001014/0000898432-19-001014-index.htm |
| 2020-08-05 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1124105/000089843220000701/0000898432-20-000701-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1124105/000089914019000220/0000899140-19-000220-index.htm |
| 2019-03-01 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1124105/000092189519000615/0000921895-19-000615-index.htm |
| 2019-07-23 | SC 13D | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1124105/000092189519002032/0000921895-19-002032-index.htm |
| 2020-08-05 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1124105/000093583620000434/0000935836-20-000434-index.htm |
| 2019-12-31 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1124105/000101143819000163/0001011438-19-000163-index.htm |
| 2020-01-17 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1124105/000101143820000029/0001011438-20-000029-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1124105/000101359419000182/0001013594-19-000182-index.htm |
| 2019-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1124105/000103738919000100/0001037389-19-000100-index.htm |
| 2020-02-11 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1124105/000110465920016494/0001104659-20-016494-index.htm |
| 2020-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1124105/000110465920019178/0001104659-20-019178-index.htm |
| 2019-02-14 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1124105/000114420419007804/0001144204-19-007804-index.htm |
| 2018-08-31 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1124105/000119312518265035/0001193125-18-265035-index.htm |
| 2018-11-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1124105/000119312518315735/0001193125-18-315735-index.htm |
| 2018-12-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1124105/000119312518352172/0001193125-18-352172-index.htm |
| 2018-12-21 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1124105/000119312518356322/0001193125-18-356322-index.htm |
| 2019-01-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1124105/000119312519017185/0001193125-19-017185-index.htm |
| 2019-02-11 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1124105/000119312519033881/0001193125-19-033881-index.htm |
| 2019-03-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1124105/000119312519067204/0001193125-19-067204-index.htm |
| 2019-04-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1124105/000119312519095661/0001193125-19-095661-index.htm |
| 2019-05-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1124105/000119312519133882/0001193125-19-133882-index.htm |
| 2019-05-02 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1124105/000119312519134826/0001193125-19-134826-index.htm |
| 2019-05-02 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1124105/000119312519134829/0001193125-19-134829-index.htm |
| 2019-06-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1124105/000119312519174848/0001193125-19-174848-index.htm |
| 2019-08-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1124105/000119312519210869/0001193125-19-210869-index.htm |
| 2019-08-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1124105/000119312519234135/0001193125-19-234135-index.htm |
| 2019-10-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1124105/000119312519261180/0001193125-19-261180-index.htm |
| 2019-10-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1124105/000119312519267593/0001193125-19-267593-index.htm |
| 2019-11-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1124105/000119312519286653/0001193125-19-286653-index.htm |
| 2019-12-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1124105/000119312519321013/0001193125-19-321013-index.htm |
| 2020-01-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1124105/000119312520003521/0001193125-20-003521-index.htm |
| 2020-01-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1124105/000119312520009556/0001193125-20-009556-index.htm |
| 2020-01-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1124105/000119312520018373/0001193125-20-018373-index.htm |
| 2020-02-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1124105/000119312520027470/0001193125-20-027470-index.htm |
| 2020-02-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1124105/000119312520027476/0001193125-20-027476-index.htm |
| 2020-02-12 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1124105/000119312520033233/0001193125-20-033233-index.htm |
| 2020-02-14 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1124105/000119312520035993/0001193125-20-035993-index.htm |
| 2020-02-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1124105/000119312520036011/0001193125-20-036011-index.htm |
| 2020-02-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1124105/000119312520043867/0001193125-20-043867-index.htm |
| 2020-03-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1124105/000119312520080653/0001193125-20-080653-index.htm |
| 2020-05-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1124105/000119312520139075/0001193125-20-139075-index.htm |
| 2020-06-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1124105/000119312520169647/0001193125-20-169647-index.htm |
| 2020-06-17 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1124105/000119312520171296/0001193125-20-171296-index.htm |
| 2020-06-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1124105/000119312520171303/0001193125-20-171303-index.htm |
| 2020-06-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1124105/000119312520172413/0001193125-20-172413-index.htm |
| 2020-06-19 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1124105/000119312520174044/0001193125-20-174044-index.htm |
| 2020-06-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1124105/000119312520174052/0001193125-20-174052-index.htm |
| 2020-07-06 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1124105/000119312520187934/0001193125-20-187934-index.htm |
| 2020-08-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1124105/000119312520211965/0001193125-20-211965-index.htm |
| 2020-09-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1124105/000119312520248122/0001193125-20-248122-index.htm |
| 2020-11-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1124105/000119312520286273/0001193125-20-286273-index.htm |
| 2019-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1124105/000119380519000178/0001193805-19-000178-index.htm |
| 2018-09-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919118049987/0001209191-18-049987-index.htm |
| 2018-11-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919118059044/0001209191-18-059044-index.htm |
| 2018-11-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919118060006/0001209191-18-060006-index.htm |
| 2019-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919119001218/0001209191-19-001218-index.htm |
| 2019-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919119001219/0001209191-19-001219-index.htm |
| 2019-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919119001221/0001209191-19-001221-index.htm |
| 2019-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919119001224/0001209191-19-001224-index.htm |
| 2019-01-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919119005666/0001209191-19-005666-index.htm |
| 2019-01-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919119005667/0001209191-19-005667-index.htm |
| 2019-01-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919119005668/0001209191-19-005668-index.htm |
| 2019-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919119006857/0001209191-19-006857-index.htm |
| 2019-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919119006858/0001209191-19-006858-index.htm |
| 2019-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919119006862/0001209191-19-006862-index.htm |
| 2019-02-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919119009704/0001209191-19-009704-index.htm |
| 2019-02-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919119009705/0001209191-19-009705-index.htm |
| 2019-02-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919119009885/0001209191-19-009885-index.htm |
| 2019-02-14 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919119010478/0001209191-19-010478-index.htm |
| 2019-04-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919119022525/0001209191-19-022525-index.htm |
| 2019-04-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919119022530/0001209191-19-022530-index.htm |
| 2019-04-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919119022537/0001209191-19-022537-index.htm |
| 2019-04-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919119022543/0001209191-19-022543-index.htm |
| 2019-05-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919119031947/0001209191-19-031947-index.htm |
| 2019-05-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919119031970/0001209191-19-031970-index.htm |
| 2019-05-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919119032871/0001209191-19-032871-index.htm |
| 2019-06-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919119037567/0001209191-19-037567-index.htm |
| 2019-06-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919119037568/0001209191-19-037568-index.htm |
| 2019-06-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919119037569/0001209191-19-037569-index.htm |
| 2019-06-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919119037571/0001209191-19-037571-index.htm |
| 2019-06-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919119037572/0001209191-19-037572-index.htm |
| 2019-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919119040314/0001209191-19-040314-index.htm |
| 2019-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919119040358/0001209191-19-040358-index.htm |
| 2019-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919119040360/0001209191-19-040360-index.htm |
| 2019-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919119040363/0001209191-19-040363-index.htm |
| 2019-08-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919119045504/0001209191-19-045504-index.htm |
| 2019-08-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919119045506/0001209191-19-045506-index.htm |
| 2019-09-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919119050610/0001209191-19-050610-index.htm |
| 2019-10-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919119051609/0001209191-19-051609-index.htm |
| 2019-10-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919119051614/0001209191-19-051614-index.htm |
| 2019-10-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919119051620/0001209191-19-051620-index.htm |
| 2019-10-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919119051626/0001209191-19-051626-index.htm |
| 2020-01-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919120000334/0001209191-20-000334-index.htm |
| 2020-01-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919120000337/0001209191-20-000337-index.htm |
| 2020-01-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919120000340/0001209191-20-000340-index.htm |
| 2020-01-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919120000342/0001209191-20-000342-index.htm |
| 2020-01-17 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919120003924/0001209191-20-003924-index.htm |
| 2020-01-17 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919120003929/0001209191-20-003929-index.htm |
| 2020-01-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919120003937/0001209191-20-003937-index.htm |
| 2020-01-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919120003942/0001209191-20-003942-index.htm |
| 2020-01-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919120004965/0001209191-20-004965-index.htm |
| 2020-01-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919120004966/0001209191-20-004966-index.htm |
| 2020-01-27 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919120005062/0001209191-20-005062-index.htm |
| 2020-01-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919120005063/0001209191-20-005063-index.htm |
| 2020-01-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919120005064/0001209191-20-005064-index.htm |
| 2020-02-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919120009039/0001209191-20-009039-index.htm |
| 2020-02-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919120009040/0001209191-20-009040-index.htm |
| 2020-02-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919120009041/0001209191-20-009041-index.htm |
| 2020-02-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919120012454/0001209191-20-012454-index.htm |
| 2020-02-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919120013392/0001209191-20-013392-index.htm |
| 2020-03-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919120016061/0001209191-20-016061-index.htm |
| 2020-03-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919120019037/0001209191-20-019037-index.htm |
| 2020-03-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919120019038/0001209191-20-019038-index.htm |
| 2020-03-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919120019040/0001209191-20-019040-index.htm |
| 2020-03-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919120019584/0001209191-20-019584-index.htm |
| 2020-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919120023174/0001209191-20-023174-index.htm |
| 2020-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919120023182/0001209191-20-023182-index.htm |
| 2020-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919120023187/0001209191-20-023187-index.htm |
| 2020-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919120023191/0001209191-20-023191-index.htm |
| 2020-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919120023199/0001209191-20-023199-index.htm |
| 2020-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919120023204/0001209191-20-023204-index.htm |
| 2020-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919120036311/0001209191-20-036311-index.htm |
| 2020-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919120036312/0001209191-20-036312-index.htm |
| 2020-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919120036313/0001209191-20-036313-index.htm |
| 2020-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919120036315/0001209191-20-036315-index.htm |
| 2020-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919120036316/0001209191-20-036316-index.htm |
| 2020-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919120036319/0001209191-20-036319-index.htm |
| 2020-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919120040377/0001209191-20-040377-index.htm |
| 2020-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919120040386/0001209191-20-040386-index.htm |
| 2020-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919120040391/0001209191-20-040391-index.htm |
| 2020-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919120040397/0001209191-20-040397-index.htm |
| 2020-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919120040405/0001209191-20-040405-index.htm |
| 2020-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919120040412/0001209191-20-040412-index.htm |
| 2020-07-02 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919120040421/0001209191-20-040421-index.htm |
| 2020-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919120040433/0001209191-20-040433-index.htm |
| 2020-08-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919120046347/0001209191-20-046347-index.htm |
| 2020-08-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919120046348/0001209191-20-046348-index.htm |
| 2020-10-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919120053117/0001209191-20-053117-index.htm |
| 2020-10-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919120053119/0001209191-20-053119-index.htm |
| 2020-10-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919120053123/0001209191-20-053123-index.htm |
| 2020-10-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919120053130/0001209191-20-053130-index.htm |
| 2020-10-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1124105/000120919120053132/0001209191-20-053132-index.htm |
| 2019-05-14 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1124105/000121465919003485/0001214659-19-003485-index.htm |
| 2020-02-07 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1124105/000121465920001083/0001214659-20-001083-index.htm |
| 2020-02-12 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1124105/000125889720000854/0001258897-20-000854-index.htm |
| 2019-07-15 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1124105/000131924419000063/0001319244-19-000063-index.htm |
| 2020-01-17 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1124105/000131924420000011/0001319244-20-000011-index.htm |
| 2019-02-14 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1124105/000149315219001853/0001493152-19-001853-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1124105/000149315219001944/0001493152-19-001944-index.htm |
| 2020-08-06 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1124105/000154600720000017/0001546007-20-000017-index.htm |
| 2020-08-06 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1124105/000154600720000018/0001546007-20-000018-index.htm |
| 2018-11-01 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1124105/000156459018026288/0001564590-18-026288-index.htm |
| 2019-03-08 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1124105/000156459019006879/0001564590-19-006879-index.htm |
| 2019-04-29 | 10-K/A | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1124105/000156459019013422/0001564590-19-013422-index.htm |
| 2019-05-02 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1124105/000156459019015316/0001564590-19-015316-index.htm |
| 2019-08-01 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1124105/000156459019027987/0001564590-19-027987-index.htm |
| 2019-11-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1124105/000156459019041706/0001564590-19-041706-index.htm |
| 2020-02-20 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1124105/000156459020005546/0001564590-20-005546-index.htm |
| 2020-05-01 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1124105/000156459020020531/0001564590-20-020531-index.htm |
| 2020-05-01 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1124105/000156459020020537/0001564590-20-020537-index.htm |
| 2020-05-11 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1124105/000156459020023982/0001564590-20-023982-index.htm |
| 2020-08-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1124105/000156459020037483/0001564590-20-037483-index.htm |
| 2020-11-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1124105/000156459020051083/0001564590-20-051083-index.htm |
| 2019-02-11 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1124105/000168788819000002/0001687888-19-000002-index.htm |
| 2019-02-14 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1124105/999999999519000263/9999999995-19-000263-index.htm |
Catalyst Biosciences, Inc (CBIO) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Catalyst Biosciences, Inc (CBIO). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 455%Institutional Ownership: 6458%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2020-02-25 | AUGUSTINE LAWLOR | Director | Sell | 69,401.00 | 6.10 | 423,505.72 | 0.00 | https://www.sec.gov/Archives/edgar/data/1124105/000120919120012454/0001209191-20-012454-index.htm |
| 2019-05-21 | NASSIM USMAN | President & CEO | Buy | 4,400.00 | 4.63 | 20,372.00 | 10,567.00 | https://www.sec.gov/Archives/edgar/data/1124105/000120919119031970/0001209191-19-031970-index.htm |
| 2020-03-04 | Eddie Williams | Director | Buy | 2,000.00 | 5.78 | 11,560.00 | 10,839.00 | https://www.sec.gov/Archives/edgar/data/1124105/000120919120016061/0001209191-20-016061-index.htm |
| 2020-03-13 | NASSIM USMAN | President & CEO | Buy | 4,000.00 | 3.91 | 15,647.20 | 11,010.00 | https://www.sec.gov/Archives/edgar/data/1124105/000120919120019040/0001209191-20-019040-index.htm |
| 2019-01-31 | NASSIM USMAN | President & CEO | Buy | 5,729.00 | 4.63 | 26,525.27 | 11,041.00 | https://www.sec.gov/Archives/edgar/data/1124105/000120919119006857/0001209191-19-006857-index.htm |
| 2020-08-10 | NASSIM USMAN | President & CEO | Buy | 582.00 | 4.81 | 2,799.42 | 11,592.00 | https://www.sec.gov/Archives/edgar/data/1124105/000120919120046348/0001209191-20-046348-index.htm |
| 2020-10-01 | Andrea Hunt | Director | Buy | 2,761.00 | 11,636.00 | https://www.sec.gov/Archives/edgar/data/1124105/000120919120053119/0001209191-20-053119-index.htm | ||
| 2019-02-11 | Howard Levy | Chief Medical Officer | Buy | 2,485.00 | 7.04 | 17,494.40 | 11,867.00 | https://www.sec.gov/Archives/edgar/data/1124105/000120919119009704/0001209191-19-009704-index.htm |
| 2018-09-06 | STEPHEN A HILL | Director | Sell | 190.00 | 10.07 | 1,913.30 | 1,190.00 | https://www.sec.gov/Archives/edgar/data/1124105/000120919118049987/0001209191-18-049987-index.htm |
| 2019-05-24 | John P Richard | Director | Buy | 1,000.00 | 8.03 | 8,030.00 | 1,216.00 | https://www.sec.gov/Archives/edgar/data/1124105/000120919119032871/0001209191-19-032871-index.htm |
| 2019-10-01 | AUGUSTINE LAWLOR | Director | Buy | 4,391.00 | 12,442.00 | https://www.sec.gov/Archives/edgar/data/1124105/000120919119051620/0001209191-19-051620-index.htm | ||
| 2020-04-01 | ERROL B DESOUZA | Director | Buy | 2,860.00 | 12,498.00 | https://www.sec.gov/Archives/edgar/data/1124105/000120919120023174/0001209191-20-023174-index.htm | ||
| 2020-04-01 | Eddie Williams | Director | Buy | 2,717.00 | 13,556.00 | https://www.sec.gov/Archives/edgar/data/1124105/000120919120023204/0001209191-20-023204-index.htm | ||
| 2020-02-10 | Howard Levy | Chief Medical Officer | Buy | 1,358.00 | 6.23 | 8,460.34 | 1,358.00 | https://www.sec.gov/Archives/edgar/data/1124105/000120919120009040/0001209191-20-009040-index.htm |
| 2020-07-01 | Eddie Williams | Director | Buy | 1,011.00 | 14,567.00 | https://www.sec.gov/Archives/edgar/data/1124105/000120919120040412/0001209191-20-040412-index.htm | ||
| 2020-07-01 | ERROL B DESOUZA | Director | Buy | 2,129.00 | 14,627.00 | https://www.sec.gov/Archives/edgar/data/1124105/000120919120040377/0001209191-20-040377-index.htm | ||
| 2019-04-01 | Andrea Hunt | Director | Buy | 717.00 | 1,528.00 | https://www.sec.gov/Archives/edgar/data/1124105/000120919119022530/0001209191-19-022530-index.htm | ||
| 2020-01-02 | AUGUSTINE LAWLOR | Director | Buy | 3,166.00 | 15,608.00 | https://www.sec.gov/Archives/edgar/data/1124105/000120919120000340/0001209191-20-000340-index.htm | ||
| 2020-10-01 | Eddie Williams | Director | Buy | 1,380.00 | 15,947.00 | https://www.sec.gov/Archives/edgar/data/1124105/000120919120053132/0001209191-20-053132-index.htm | ||
| 2019-05-21 | Howard Levy | Chief Medical Officer | Buy | 4,400.00 | 4.63 | 20,372.00 | 16,094.00 | https://www.sec.gov/Archives/edgar/data/1124105/000120919119031947/0001209191-19-031947-index.htm |
| 2018-12-31 | Eddie Williams | Director | Buy | 1,544.00 | 1,672.00 | https://www.sec.gov/Archives/edgar/data/1124105/000120919119001224/0001209191-19-001224-index.htm | ||
| 2020-10-01 | ERROL B DESOUZA | Director | Buy | 3,125.00 | 17,752.00 | https://www.sec.gov/Archives/edgar/data/1124105/000120919120053117/0001209191-20-053117-index.htm | ||
| 2020-04-01 | SHARON TETLOW | Director | Buy | 1,932.00 | 1,932.00 | https://www.sec.gov/Archives/edgar/data/1124105/000120919120023199/0001209191-20-023199-index.htm | ||
| 2018-12-31 | ERROL B DESOUZA | Director | Buy | 1,703.00 | 1,944.00 | https://www.sec.gov/Archives/edgar/data/1124105/000120919119001218/0001209191-19-001218-index.htm | ||
| 2020-04-01 | AUGUSTINE LAWLOR | Director | Buy | 4,934.00 | 20,542.00 | https://www.sec.gov/Archives/edgar/data/1124105/000120919120023187/0001209191-20-023187-index.htm | ||
| 2020-07-01 | AUGUSTINE LAWLOR | Director | Buy | 3,673.00 | 24,215.00 | https://www.sec.gov/Archives/edgar/data/1124105/000120919120040391/0001209191-20-040391-index.htm | ||
| 2020-03-16 | Howard Levy | Chief Medical Officer | Buy | 2,500.00 | 4.05 | 10,131.50 | 2,500.00 | https://www.sec.gov/Archives/edgar/data/1124105/000120919120019584/0001209191-20-019584-index.htm |
| 2019-07-01 | Andrea Hunt | Director | Buy | 1,036.00 | 2,564.00 | https://www.sec.gov/Archives/edgar/data/1124105/000120919119040358/0001209191-19-040358-index.htm | ||
| 2018-12-31 | AUGUSTINE LAWLOR | Director | Buy | 2,732.00 | 2,732.00 | https://www.sec.gov/Archives/edgar/data/1124105/000120919119001221/0001209191-19-001221-index.htm | ||
| 2020-02-25 | Geoffrey M.D. Ling | Director | Buy | 3,000.00 | 6.23 | 18,691.50 | 3,000.00 | https://www.sec.gov/Archives/edgar/data/1124105/000120919120013392/0001209191-20-013392-index.htm |
| 2019-04-01 | Eddie Williams | Director | Buy | 1,364.00 | 3,036.00 | https://www.sec.gov/Archives/edgar/data/1124105/000120919119022543/0001209191-19-022543-index.htm | ||
| 2019-02-04 | Fletcher Payne | Chief Financial Officer | Buy | 1,503.00 | 4.63 | 6,958.89 | 3,230.00 | https://www.sec.gov/Archives/edgar/data/1124105/000120919119006858/0001209191-19-006858-index.htm |
| 2019-04-01 | ERROL B DESOUZA | Director | Buy | 1,504.00 | 3,448.00 | https://www.sec.gov/Archives/edgar/data/1124105/000120919119022525/0001209191-19-022525-index.htm | ||
| 2020-07-01 | SHARON TETLOW | Director | Buy | 1,703.00 | 3,635.00 | https://www.sec.gov/Archives/edgar/data/1124105/000120919120040405/0001209191-20-040405-index.htm | ||
| 2020-03-13 | John P Richard | Director | Buy | 2,500.00 | 3.98 | 9,950.00 | 3,716.00 | https://www.sec.gov/Archives/edgar/data/1124105/000120919120019038/0001209191-20-019038-index.htm |
| 2019-02-11 | Fletcher Payne | Chief Financial Officer | Buy | 1,002.00 | 7.04 | 7,054.08 | 3,731.00 | https://www.sec.gov/Archives/edgar/data/1124105/000120919119009885/0001209191-19-009885-index.htm |
| 2019-08-12 | Fletcher Payne | Chief Financial Officer | Buy | 1,180.00 | 6.51 | 7,681.80 | 3,744.00 | https://www.sec.gov/Archives/edgar/data/1124105/000120919119045506/0001209191-19-045506-index.htm |
| 2019-10-01 | Andrea Hunt | Director | Buy | 1,489.00 | 4,053.00 | https://www.sec.gov/Archives/edgar/data/1124105/000120919119051614/0001209191-19-051614-index.htm | ||
| 2020-08-10 | Howard Levy | Chief Medical Officer | Buy | 1,768.00 | 4.81 | 8,504.08 | 4,268.00 | https://www.sec.gov/Archives/edgar/data/1124105/000120919120046347/0001209191-20-046347-index.htm |
| 2019-07-01 | Eddie Williams | Director | Buy | 1,642.00 | 4,678.00 | https://www.sec.gov/Archives/edgar/data/1124105/000120919119040363/0001209191-19-040363-index.htm | ||
| 2020-04-01 | Geoffrey M.D. Ling | Director | Buy | 1,932.00 | 4,932.00 | https://www.sec.gov/Archives/edgar/data/1124105/000120919120023191/0001209191-20-023191-index.htm | ||
| 2020-10-01 | AUGUSTINE LAWLOR | Director | Buy | 5,014.00 | 5,014.00 | https://www.sec.gov/Archives/edgar/data/1124105/000120919120053123/0001209191-20-053123-index.htm | ||
| 2020-01-02 | Andrea Hunt | Director | Buy | 1,073.00 | 5,126.00 | https://www.sec.gov/Archives/edgar/data/1124105/000120919120000337/0001209191-20-000337-index.htm | ||
| 2019-04-01 | AUGUSTINE LAWLOR | Director | Buy | 2,414.00 | 5,146.00 | https://www.sec.gov/Archives/edgar/data/1124105/000120919119022537/0001209191-19-022537-index.htm | ||
| 2019-07-01 | ERROL B DESOUZA | Director | Buy | 1,810.00 | 5,258.00 | https://www.sec.gov/Archives/edgar/data/1124105/000120919119040314/0001209191-19-040314-index.htm | ||
| 2020-02-10 | Veronica Cai | Controller | Buy | 1,678.00 | 6.23 | 10,453.94 | 5,353.00 | https://www.sec.gov/Archives/edgar/data/1124105/000120919120009039/0001209191-20-009039-index.htm |
| 2019-02-11 | NASSIM USMAN | President & CEO | Buy | 350.00 | 7.04 | 2,464.00 | 6,167.00 | https://www.sec.gov/Archives/edgar/data/1124105/000120919119009705/0001209191-19-009705-index.htm |
| 2019-08-12 | NASSIM USMAN | President & CEO | Buy | 413.00 | 6.51 | 2,688.63 | 6,580.00 | https://www.sec.gov/Archives/edgar/data/1124105/000120919119045504/0001209191-19-045504-index.htm |
| 2020-07-01 | Geoffrey M.D. Ling | Director | Buy | 1,703.00 | 6,635.00 | https://www.sec.gov/Archives/edgar/data/1124105/000120919120040397/0001209191-20-040397-index.htm | ||
| 2020-04-01 | Andrea Hunt | Director | Buy | 1,673.00 | 6,799.00 | https://www.sec.gov/Archives/edgar/data/1124105/000120919120023182/0001209191-20-023182-index.htm | ||
| 2020-02-10 | NASSIM USMAN | President & CEO | Buy | 430.00 | 6.23 | 2,678.90 | 7,010.00 | https://www.sec.gov/Archives/edgar/data/1124105/000120919120009041/0001209191-20-009041-index.htm |
| 2019-10-01 | Eddie Williams | Director | Buy | 2,418.00 | 7,096.00 | https://www.sec.gov/Archives/edgar/data/1124105/000120919119051626/0001209191-19-051626-index.htm | ||
| 2020-03-13 | Veronica Cai | Controller | Buy | 2,000.00 | 4.11 | 8,220.00 | 7,353.00 | https://www.sec.gov/Archives/edgar/data/1124105/000120919120019037/0001209191-20-019037-index.htm |
| 2018-11-16 | Howard Levy | Chief Medical Officer | Sell | 173.00 | 11.00 | 1,903.00 | 7,560.00 | https://www.sec.gov/Archives/edgar/data/1124105/000120919118059044/0001209191-18-059044-index.htm |
| 2018-11-26 | Howard Levy | Chief Medical Officer | Buy | 149.00 | 4.63 | 689.87 | 7,709.00 | https://www.sec.gov/Archives/edgar/data/1124105/000120919118060006/0001209191-18-060006-index.htm |
| 2018-11-16 | Howard Levy | Chief Medical Officer | Buy | 173.00 | 4.63 | 800.99 | 7,733.00 | https://www.sec.gov/Archives/edgar/data/1124105/000120919118059044/0001209191-18-059044-index.htm |
| 2019-10-01 | ERROL B DESOUZA | Director | Buy | 2,545.00 | 7,803.00 | https://www.sec.gov/Archives/edgar/data/1124105/000120919119051609/0001209191-19-051609-index.htm | ||
| 2019-07-01 | AUGUSTINE LAWLOR | Director | Buy | 2,905.00 | 8,051.00 | https://www.sec.gov/Archives/edgar/data/1124105/000120919119040360/0001209191-19-040360-index.htm | ||
| 2018-12-31 | Andrea Hunt | Director | Buy | 811.00 | 811.00 | https://www.sec.gov/Archives/edgar/data/1124105/000120919119001219/0001209191-19-001219-index.htm | ||
| 2020-01-02 | Eddie Williams | Director | Buy | 1,743.00 | 8,839.00 | https://www.sec.gov/Archives/edgar/data/1124105/000120919120000342/0001209191-20-000342-index.htm | ||
| 2020-07-01 | Andrea Hunt | Director | Buy | 2,076.00 | 8,875.00 | https://www.sec.gov/Archives/edgar/data/1124105/000120919120040386/0001209191-20-040386-index.htm | ||
| 2020-10-01 | Geoffrey M.D. Ling | Director | Buy | 2,616.00 | 9,251.00 | https://www.sec.gov/Archives/edgar/data/1124105/000120919120053130/0001209191-20-053130-index.htm | ||
| 2019-01-31 | Howard Levy | Chief Medical Officer | Buy | 1,500.00 | 4.63 | 6,945.00 | 9,382.00 | https://www.sec.gov/Archives/edgar/data/1124105/000120919119006862/0001209191-19-006862-index.htm |
| 2020-01-02 | ERROL B DESOUZA | Director | Buy | 1,835.00 | 9,638.00 | https://www.sec.gov/Archives/edgar/data/1124105/000120919120000334/0001209191-20-000334-index.htm |